Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?

Benzer Materyaller

• Glycated hemoglobin variability and retinopathy progression in type 1 diabetes: Is month‐to‐moth instability a better predictor?
  Yazar:: Chang, Chia‐Hsuin, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs
  Yazar:: Poon, Kitty, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
  Yazar:: Lin, Chun‐Hsien, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction
  Yazar:: Chang, Chia‐Hsuin, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Long-acting basal insulin analogs: latest developments and clinical usefulness
  Yazar:: Mavrogiannaki, Anastasia N., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)